Back to Search

JOHN MCHUTCHISON, MD

MD

Gastroenterology Physician

NPI: 1467536375Individual

Specialties, Licenses & Credentials

Gastroenterology PhysicianPrimary

Internal Medicine — Gastroenterology

Code: 207RG0100X

Research & Publications (20)

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
PMID 19625712·N Engl J Med·2009
4-observational
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
PMID 19403902·N Engl J Med·2009
3-trial
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
PMID 18081733·Aliment Pharmacol Ther·2008
4-observational
Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
PMID 18363672·J Viral Hepat·2008
3-trial
Making it happen: managed care considerations in vanquishing hepatitis C.
PMID 18095781·Am J Manag Care·2007
6-review
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
PMID 18046027·N Engl J Med·2007
3-trial
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.
PMID 17929306·Hepatology·2007
3-trial
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
PMID 17397412·Am J Gastroenterol·2007
6-review
The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
PMID 16364491·J Hepatol·2006
6-review
Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.
PMID 16979947·Clin Gastroenterol Hepatol·2006
6-review
Definition and management of anemia in patients infected with hepatitis C virus.
PMID 16629641·Liver Int·2006
6-review
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.
PMID 16274834·J Hepatol·2006
3-trial
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
PMID 16152757·Antivir Ther·2005
3-trial
Chronic hepatitis C: an age wave of disease burden.
PMID 16232012·Am J Manag Care·2005
6-review
Hepatitis C: a 20-year debt comes due.
PMID 15084063·Am J Manag Care·2004
8-other
Future trends in managing hepatitis C.
PMID 15081103·Gastroenterol Clin North Am·2004
8-other
Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?
PMID 16265063·Nat Clin Pract Gastroenterol Hepatol·2004
8-other
Understanding hepatitis C.
PMID 15084064·Am J Manag Care·2004
4-observational
Current therapy for hepatitis C: pegylated interferon and ribavirin.
PMID 12691464·Clin Liver Dis·2003
6-review
Future therapy of hepatitis C.
PMID 12407600·Hepatology·2002
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2100 ERWIN RD
DURHAM, NC 27710

Location

Practice Location

2100 ERWIN RD, DURHAM, NC
(919) 620-4467

Quick Facts

NPI
1467536375
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile